In 2022, the Mexican federal government amended its Common Health Legislation to require that all clinical prescriptions, marketing and advertising, as well as other references utilize the generic identify when referring to some medication, as opposed to a selected manufacturer title. Based on Mexico’s Secretary of Financial system Tatiana Clo